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Abstract 29 
High concentrations of caffeine and taurine are key constitutes of many ergogenic supplements 30 
ingested acutely to provide legal enhancements in athlete performance. Despite this, there is little 31 
evidence supporting the performance enhancing effects of acute taurine supplementation. In vitro 32 
models have demonstrated that a caffeine induced muscle contracture can be further potentiated 33 
when combined with a high concentration of taurine. However, the high concentration of caffeine 34 
used in previous research would be toxic for human consumption. Therefore the present study aims 35 
to investigate the direct effect of a physiological dose of caffeine and taurine to potentiate skeletal 36 
muscle performance.  Isolated mouse soleus muscle was used to examine the effects of physiological 37 
taurine (TAU), caffeine (CAF), and taurine-caffeine combined (TC) on:  1) acute muscle power output; 38 
2) time to fatigue; and 3) fatigue recovery, compared to untreated controls (CON). Treatment with 39 
TAU failed to elicit any significant difference in the measured parameters. Treatment with TC 40 
resulted in a significant increase in acute muscle power output and faster time to fatigue. The 41 
ergogenic benefit posed by TC was not different from the effects of caffeine alone, suggesting no 42 
acute ergogenic benefit of taurine. 43 
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Introduction 51 
The ergogenic effect of energy drinks to promote legal enhancements in sporting performance is 52 
largely attributed to high concentrations of caffeine due to the corresponding wealth of evidence 53 
demonstrating positive effects across endurance, power and strength activities (Alford et al. 2001; 54 
Davis & Green, 2009; Duncan & Oxford, 2011; Graham et al. 2001,). In addition to high 55 
concentrations of caffeine and various sugars, the amino acid taurine (Amino Ethane Sulfonic Acid) is 56 
a constituent of many energy drinks and is believed to contribute to the performance enhancing 57 
effect (Geib et al. 1994). Despite this there is little evidence to demonstrate an acute ergogenic 58 
effect of taurine. 59 
Found in high concentrations in mammalian tissue, taurine is readily synthesized by the body and 60 
although the exact mechanisms of action are unclear, evidence suggests relationships to the 61 
functions of osmoregulation, regulation of oxidative stress, and cell signalling (Cuisinier et al. 2002; 62 
Matsuzaki et al. 2002; Oja & Saransaari, 2007; Schaffer et al. 2010). It is further suggested that 63 
taurine plays a role in maintaining mammalian myocardial and skeletal muscle contractile function 64 
(Schaffer et al. 2010). Warskulat et al. (2004) used taurine transporter knockout mice to 65 
demonstrate that the almost complete depletion of skeletal muscle taurine reduced exercise 66 
capacity by over 80%. Reducing the intracellular concentration of taurine has commonly been shown 67 
to result in a reduction in skeletal muscle function, primarily resulting in a decrease in muscle force 68 
production (Hamilton et al. 2006). Evidence is also presented to suggest that depletion of muscular 69 
taurine occurs during prolonged muscle activation (Kim et al. 1986; Matsuzaki et al. 2002), therefore 70 
suggesting a link between fatigue and muscular taurine concentration. 71 
In vivo and in vitro evidence suggests that chronic taurine supplementation can positively enhance 72 
skeletal muscle performance (Imagawa et al. 2009). Chronic taurine supplementation in rats has 73 
been shown to lead to large increases in muscle taurine concentration and a consequential 74 
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enhancement of muscle force. This in turn has been shown to correspond to an increase in SR Ca2+ 75 
storage protein, calsequestrin, which potentially relates to a greater intramuscular Ca2+ 76 
concentration following muscle activation (Goodman et al. 2009). 77 
Geib et al. (1994) concluded that ‘Red Bull’ energy drink had a greater effect at increasing cycling 78 
endurance time in endurance trained male athletes if the taurine content was present, but generally 79 
the evidence discussing the effect of acute taurine supplementation on physiological performance is 80 
sparse. In vitro, high concentrations of taurine have been shown to increase isometric force in fast 81 
skeletal muscles of rat and slow abdominal extensor muscle of crayfish (Bakker & Berg 2002; Galler 82 
& Hutzler, 1990). The mechanism of action is believed to be modification of ion channel function and 83 
an increase in Ca2+ sensitivity of the myofilaments (Camerino et al. 2004; Bakker & Berg 2002; 84 
Cuisiner et al. 2000; Galler & Hutzler, 1990). Furthermore, a limited number of diverse studies 85 
examining skinned rat heart to whole body human performance have demonstrated that taurine, 86 
when combined with caffeine, can result in further potentiation of the effects of caffeine alone (Geib 87 
et al. 1994; Steele et al. 1990). However, this effect has never been established using physiologically 88 
relevant concentrations of taurine and caffeine to examine their direct effects on skeletal muscle.  89 
The ergogenic properties of physiologically relevant concentrations (50-70µM) of caffeine on muscle 90 
power output and fatigue have previously been evaluated (James et al. 2005; Tallis et al. 2012, 91 
2013), and in agreement with the potential effect of taurine, modification in performance is 92 
attributed to changes in intramuscular Ca2+ handling (Bhat, 1997; Daminai et al. 1996; Davis & Green, 93 
2009; Fredholm et al. 1997; Magkos & Kavouras, 2005; Rossi et al. 2001).  94 
The present study aims to uniquely assess if an acute physiological dose of taurine is sufficient to 95 
improve muscular power and offset fatigue, and is the first to determine whether the ergogenic 96 
effect of caffeine is augmented when combined with taurine when both are at a physiological 97 
concentration. This research uses the work look technique as a closer representation of in vivo 98 
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muscle performance to compare the direct effects of physiologically relevant concentrations of 99 
taurine alone (2.64mM), caffeine alone (70µM), and taurine and caffeine combined on: 1) acute 100 
maximal muscle power output; 2) time to fatigue; 3) recovery following fatigue on isolated mouse 101 
soleus muscle.   102 
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Materials and Methods 118 
Animals  119 
The use of animals in this study was approved by the ethics committee of Coventry University. 120 
Female white mice (strain CD1 mice, Charles River, UK) were bred and kept at Coventry University. 8 121 
-10 week old mice (body mass = 31.1±0.24 g, mean ± SE, n =72) were weighed and then killed by 122 
cervical dislocation in accordance with British Home Office Animals (Scientific Procedures) Act 1986, 123 
Schedule 1. 124 
Soleus muscle was isolated from the right hind limb and pinned out at approximately its resting 125 
length at room temperature (19-21 oC). During dissection the muscle preparation was maintained in 126 
cooled (refrigerated) and frequently changed oxygenated (95% O2; 5% CO2) Krebs-Henseleit solution 127 
of composition (mM) NaCl 118; KCl 4.75; MgSO4 1.18; NaHCO3 24.8; KH2PO4 1.18; glucose 10; CaCl2 128 
2.54; pH 7.55 (at room temperature prior to oxygenation). For each preparation, the tendon and a 129 
small piece of bone was left attached at the proximal and distal ends. Aluminium foil T-clips were 130 
wrapped around each tendon leaving the bone at the back of the clip to help minimise tendon 131 
slippage when the muscle was producing force (James et al. 2005). 132 
 133 
Isometric Studies 134 
Isometric studies were used to determine the twitch and tetanus kinetics of isolated mouse soleus 135 
muscle. The foil clips at either end of the muscle preparation were clamped to a force transducer 136 
(UF1, Pioden Controls Ltd, UK) or a motor arm (DFG5.0, Solartron Metrology, UK) via crocodile clips. 137 
A Linear Variable Displacement Transformer was attached to the motor arm to measure the length 138 
changes the muscle was subjected to. The whole of the muscle was maintained in a flow through 139 
chamber containing circulated oxygenated Krebs-Henseleit solution at a constant temperature of 36 140 
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± 0.02oC. 10 minutes prior to the commencement of testing the muscle was allowed to equilibrate to 141 
the new environment. The preparation was then held at a constant length and stimulated via 142 
parallel platinum electrodes to generate a series of isometric twitch responses. The electrodes were 143 
not in contact with the nerve branch or the fibre itself but stimulated the muscle via the surrounding 144 
fluid. Muscle length and stimulation amplitude (12-16V) were altered to maximise isometric twitch 145 
force. In order to elicit a tetanus response the muscle was subjected to a 320ms burst of electrical 146 
stimuli and stimulation frequency was optimised (usually 140Hz) to achieve maximal isometric 147 
tetanus force. To ensure sufficient recovery a 5 minute rest period was imposed between each 148 
tetanus. An eyepiece graticule fitted to a microscope was used to measure muscle length (defined as 149 
L0); mean muscle fibre length was then calculated as 85% of L0 (James et al. 1995). 150 
 151 
Work Loop Analysis of Muscle Power Output 152 
The work loop technique was used in order to determine muscle power output during cyclical length 153 
changes (Josephson, 1985; James et al. 1996). Muscle preparations were subjected to four sinusoidal 154 
length change cycles at a strain of 0.10 around the previously determined L0 that generated maximal 155 
isometric twitch and tetanus force. Therefore muscle lengthened by 5% from L0 followed by a 156 
shortening to 5% shorter than L0 before returning back to L0. This occurred at a 5Hz cycle frequency 157 
that had previously been determined to elicit maximal mouse soleus muscle power output and is 158 
attainable in vivo (James et al. 1995). The strain employed also comes from previous estimates of 159 
maximal power output for mouse soleus muscle and again is attainable during in vivo locomotion 160 
(James et al. 1995). The stimulation frequency and amplitude found to yield maximal isometric force 161 
were employed to stimulate the muscle during the shortening phase of the work loop. Optimising 162 
the timing of muscle stimulation during the shortening phase maximises power output. In the 163 
present study a stimulus burst duration of 65ms was used, concurrent with the methods of James et 164 
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al. (1995) and Vassilakos et al. (2009). The stimulation phase shift was fixed at -10 ms, therefore 165 
muscle stimulation started 10 ms prior to the muscle reaching its maximal length and, with a burst 166 
duration of 65 ms, continued until 45 ms prior to the muscle reaching its shortest length. Muscle 167 
stimulation and length changes were controlled using custom written software (Testpoint, CEC, 168 
Massachusetts, USA) via a D/A board (KPCI3108, Keithley Instruments, Ohio, USA).  Data were 169 
sampled at a rate of 10 kHz and then a work loop was formed, by plotting force against length, the 170 
area of which represents the net work done by the muscle during a single length change cycle 171 
(Josephson, 1985).  172 
Evidence outlining the maximal acute consumption of taurine in humans is scarce and thus research 173 
defining maximal blood plasma taurine concentration is also limited. The physiologically relevant 174 
dosage of taurine used in the present study is therefore derived from maximal doses reported in 175 
humans without toxic effect. Taurine ingestion in doses up to 6g per day and further intravenous 176 
delivery of 5g of taurine has been reported in the literature (Milei et al. 1992; Mizushima et al. 177 
1996). Based on results reported by Galloway et al. (2008) ingestion of 1.66g of taurine yields a peak 178 
blood plasma concentration of 750µM, assuming the rates of uptake and degradation scale 179 
proportionately, the present study uses a taurine concentration of 2.64mM equating to 5.8g, similar 180 
to maximal doses as previously outlined (5-6mg). 181 
In order to test whether 2.64 mM of taurine alone (TAU) or 2.64 mM taurine and 70µM caffeine 182 
combined (TC) affected acute muscle power output, time to fatigue, or recovery from fatigue, each 183 
soleus muscle preparation was subjected to one of the following protocols. i.e. each muscle 184 
preparation was used to determine the effects of treatment on acute power output or time to 185 
fatigue or recovery from fatigue. 70µM is recognised as the human physiological maximum. The 186 
caffeine only treatment data at this concentration has been published previously (Tallis et al. 2012; 187 
2013). 188 
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 Acute Power Output 189 
In order to test the acute effect of a given treatment the muscle was subjected to 4 work loop cycles 190 
at 10 minute intervals over 120 minutes. During the initial 3 measurements the muscle was 191 
maintained in standard Krebs-Henseleit solution. The fluid was then changed to Krebs-Henseleit 192 
solution containing either 2.64 mM taurine (TAU) or 2.64 mM taurine and 70µM caffeine combined 193 
(TC). This experimental treatment was maintained for 60 minutes. Following this, the solution was 194 
then changed to standard Krebs-Henseleit solution, for a wash out period of 40 minutes, to establish 195 
if the effect of treatment was reversed, returning the muscle to its pre treatment state.  The second 196 
work loop of 4 was always used as the indicative measure of muscle power output at each time 197 
point. 198 
Time to Fatigue 199 
In order to test the effect of a given treatment on time to fatigue the muscle was again subjected to 200 
sets of 4 work loops at 10 minute intervals over 130 minute duration. During the initial 3 201 
measurements (3 sets of 4 work loops) the muscle was maintained in standard Krebs-Henseleit 202 
solution. For the subsequent 40 minutes the fluid was changed to TAU or TC. The fourth 203 
measurement in the treatment solution was a fatigue run consisting of 100 consecutive work loop 204 
cycles; data was collected for every second loop. Forty minutes of incubation in the treatment 205 
solution was allowed prior to the fatigue run to give sufficient time to allow each preparation to 206 
respond to the treatment (Tallis et al. 2012; 2013). Directly after the fatigue run the circulating fluid 207 
was changed back to standard Krebs-Henseleit solution and recovery was monitored for 60 minutes. 208 
The control protocol followed the same process however the muscle was maintained in standard 209 
Krebs-Henseleit solution throughout. 210 
 211 
 212 
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Recovery from Fatigue 213 
In order to measure the effects of taurine and/or caffeine on recovery from fatigue the same fatigue 214 
protocol as above was used, however, in the time up to and inclusive of the fatigue run the muscle 215 
was incubated in standard Krebs-Henseleit solution. Immediately after the fatigue run the solution 216 
was changed to TAU, TC or Caffeine (CAF) and recovery was monitored for the next hour.  217 
 218 
Muscle Mass Measurements and Dimension Calculations 219 
At the end of the experiment the muscle was disconnected from the apparatus and the tendons and 220 
bones removed leaving the muscle intact. Following this, the muscle was blotted on tissue paper to 221 
remove excess fluid. The muscle was then placed on an electronic balance (Mettler Toledo B204-S, 222 
Zurich, Switzerland) to determine the wet muscle mass. Mean muscle cross-sectional area was 223 
calculated from mean fibre length, muscle mass and an assumed muscle density of 1060 kg m-3 224 
(Méndez and Keys 1960). Isometric stress was calculated as force divided by mean muscle cross-225 
sectional area. Muscle power output was normalised to muscle mass to express power as Watts.kg-1. 226 
 227 
Statistical Analysis of Data  228 
In order to compare the quality of muscle between treatment groups a single factor ANOVA was 229 
conducted on maximal untreated isometric stress and work loop power output data. 230 
Due to the gradual development of an anoxic core in control conditions muscle power output will 231 
slowly decrease over time (Barclay, 2005). For the muscles tested in the present study power output 232 
decreased to an average 96 ± 1% of initial power over the 120 minute duration of the work loop 233 
protocol. In order to avoid the deterioration in muscle performance masking the effects of 234 
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treatment, a 1st order regression equation was calculated using the pre treatment control data and 235 
post treatment washout control data in order to identify the linear relationship between control 236 
muscle power output and time. This regression equation was then used to determine theoretical 237 
control muscle power output for each time point during caffeine treatment (James et al. 2005; Tallis 238 
et al. 2012).  239 
Initially, for the acute power output data, pre treatment controls were compared against post 240 
treatment washout controls for each experimental group. There was no significant difference 241 
between these control data (Fig 1; paired t-test, t<0.5, P>0.6 in all cases) therefore, it was assumed 242 
that any subsequent change in muscle power when incubated in TC, TAU or CAF was an effect of the 243 
given treatment. In order to assess the effects of treatment for each acute response the control data 244 
were compared directly against treatment data via paired t-tests. A single factor ANOVA was 245 
conducted in order to identify whether the given increase in power output was different between 246 
treatments (TC vs.TAU vs. CAF). Tukey post hoc tests were used to establish where these differences 247 
occurred. 248 
A two factor ANOVA (time and treatment) was used to determine whether muscle power output 249 
changed over time. A second two factor ANOVA (time and treatment) was used to determine 250 
whether the time to fatigue differed between treatment groups. In each case Tukey post hoc tests 251 
were performed where applicable. However, single factor ANOVA were used, post hoc, at each time 252 
point in order to assess whether power output was significantly different between treatments at 253 
each time point of during the fatigue run. 254 
A two factor ANOVA (time and treatment) was implemented to identify whether power output 255 
increased significantly over recovery time and whether recovery differed between treatment groups, 256 
Tukey post hoc tests were used for treatment. Single factor ANOVA were conducted at each time 257 
point in order to identify if muscle power output differed between treatments at each time point. 258 
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Results were interpreted as significant when p < 0.05. Values are displayed as mean ± standard 259 
error. 260 
The original data regarding the effects of caffeine on maximal acute power output was taken from 261 
that used in our previous publication, Tallis et al. (2012). Similarly, the original data assessing the 262 
effects of caffeine on time to fatigue was taken from Tallis et al. (2013).  263 
 264 
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Results 278 
Comparisons between stress and power were made using only the original data presented in this 279 
study (i.e. n=76 out of the n=92 total). The mean maximal isometric twitch and tetanus stress for 280 
soleus muscle (n=76) was 38.6 ± 1.5 kN m-2 and 219 ± 7 kN m-2 respectively. Mean untreated maximal 281 
muscle power output was 32.8 ± 1 W kg-1 (n=76). Untreated mean maximal isometric tetanus stress 282 
and work loop power output were not significantly different between experimental groups (single 283 
factor ANOVA main effect F= 1.13 P=0.35 and F=0.33, P=0.95 respectively). Therefore, it is assumed 284 
that the muscles were of a similar quality between the experimental groups and that any 285 
subsequent differences in response occurred due to the effects of treatment. 286 
Mean maximal tetanus stress and power output of the original muscle samples used in the present 287 
work are comparable to those reported in previous studies using similar methods (Askew et al. 1997; 288 
James et al. 2004; Vassilakos et al. 2009). More significantly the present results for maximal stress 289 
and power output were directly comparable to the 189 and 202 kN m-2 and 31.7 and 33.1 W kg-1 290 
previously reported by Tallis et al. (2012: 2013) respectively. This signifies that all of the soleus 291 
muscle preparations used in the research by Tallis et al. were of similar quality pre-treatment, thus it 292 
was viable to use the caffeine only treatment results from Tallis et al. (2012; 2013) for comparison to 293 
the results reported in the present study, especially as it is the percentage response to treatment 294 
that is of interest.  295 
 296 
The Effect of Physiological Concentrations of Taurine and Caffeine on Muscle Power Output 297 
Treatment of soleus muscle with caffeine alone and taurine-caffeine combined resulted in a 298 
significant increase in acute maximal muscle power output of 6.4% and 4.1% respectively (Fig 1; 299 
paired t-test, t<-2.29, P<0.03 in both cases) compared to controls. Treatment with taurine alone 300 
failed to elicit any significant increase in muscle power output (Fig 1; paired t-test, t=1.586, P=0.118).  301 
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The performance enhancing benefit was significantly dependant on treatment (Fig 1; single factor 302 
ANOVA main effect F=3.59, P=0.03). There was no significant difference between the benefit 303 
imposed by caffeine alone when compared with taurine and caffeine combined (Fig 1; Tukey 304 
P=0.628). The treatment effect of caffeine was significantly higher than that of taurine alone (Fig 1; 305 
Tukey P=0.027), however there was no significant difference between taurine and caffeine 306 
combined and taurine alone (Fig 1; Tukey P=0.178). 307 
 308 
The Effect of Physiological Concentrations of Taurine and Caffeine on Time to Fatigue 309 
The fatigue protocol was effective in inducing soleus muscle fatigue as power output reduced 310 
significantly over time (Fig 2; two factor ANOVA main effect of time F=110, P<0.001). There was a 311 
significant effect of treatment on time to net negative work (Fig 2; two factor ANOVA main effect 312 
F=15.68, P<0.001). Treatment of soleus muscle with caffeine alone or with taurine and caffeine 313 
combined resulted in a significantly decreased time to fatigue (time to net negative work decreased 314 
by 30% and 15% respectively) compared to controls (Fig 2; Tukey P<0.001 in both cases). Soleus 315 
muscle treated with caffeine fatigued significantly faster than muscle treated with taurine and 316 
caffeine combined (Fig 2; Tukey P<0.001). There was no significant difference in time to fatigue 317 
between soleus muscles treated with taurine alone compared to controls (Fig 2; Tukey P<0.001). 318 
Soleus muscle treated with caffeine produced significantly less power when compared with: muscle 319 
treated with taurine from 3.2s onwards; controls from 3.6s onwards; taurine and caffeine combined 320 
from 4.8s (Fig 2; Tukey P<0.04 in all cases). There was no significant difference in the mean power 321 
output at any time point between any other treatments (Fig 2; Tukey P>0.05 in all cases). 322 
 323 
The Effect of Physiological Concentrations of Taurine and Caffeine on Recovery from Fatigue 324 
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Power output significantly increased over time during recovery from fatigue (Fig 3; two factor 325 
ANOVA main effect F=8.29, P<0.001). The level of soleus muscle recovery was not significantly 326 
dependent on treatment (Fig 3; two factor ANOVA main effect F=2.59, P=0.054). Mean muscle 327 
recovery for the entire group was 87% of the pre fatigue maximum and occurred between 80 and 90 328 
minutes following the start of the work loop protocol (Fig 3). Although during the latter stages of the 329 
measured recovery period, muscles treated with taurine and caffeine combined appeared to have 330 
reduced recovery, power output was not significantly different between treatments at any given 331 
time point during the recovery period (Fig 3; single factor ANOVA main effect p>0.156 in all cases).  332 
 333 
 334 
 335 
 336 
 337 
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 339 
 340 
 341 
 342 
 343 
 344 
 345 
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Discussion 346 
The Effect of Physiological Concentrations of Taurine and Caffeine on Muscle Power Output 347 
Treatment of mouse soleus muscle with 2.64mM of taurine failed to elicit any significant increases in 348 
mean maximal muscle power output compared to controls. When taurine was combined with 70µM 349 
caffeine, mean maximal power output was significantly increased by up to 4.1%. This acute increase 350 
in maximal power output was not significantly different from the up to 6.4% increase induced with 351 
caffeine treatment alone. Therefore, the direct treatment of soleus muscle with an acute taurine 352 
supplement failed to potentiate short term maximal power output and failed to further potentiate 353 
the effects of caffeine when compared to caffeine treatment alone.  354 
The results of the present study contradict the findings of Galler and Hutzler (1990) who 355 
demonstrated that physiological intramuscular concentrations of taurine (5mM) increased the 356 
submaximal isometric force of pig heart muscle and slow abdominal extensor muscle of crayfish. 357 
Such differences between studies may be related to the different muscle preparations used as 358 
cardiac muscle and crustacean skeletal muscle have previously been found to have different 359 
mechanical properties to vertebrate skeletal muscle. 20mM taurine treatment has previously been 360 
shown to potentiate force production of skinned rat EDL (Bakker & Berg 2002). Previous evidence 361 
suggests that the mechanism for this given increase in muscle performance following taurine 362 
treatment is largely attributed to short term modification of ion channel function,  Ca2+ homeostasis 363 
and, increased  myofilament Ca2+ sensitivity (Bakker and Berg 2002; Camerino et al. 2004; Cuisinier 364 
et al. 2000).  Additionally, Cuisinier et al. (2000) demonstrated that taurine did not modify Ca2+ 365 
sarcoplasmic reticulum uptake.  However, it has been suggested that the antioxidant properties of 366 
taurine may reduce oxidative stress on the sarcoplasmic reticulum Ca2+ pump (Schaffer et al. 2010). 367 
As no increase in acute muscle power was reported in the present study, it is suggested that taurine 368 
treatment failed to elicit improved skeletal muscle Ca2+ handling. The current research uses a 369 
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physiologically relevant taurine concentration (2.64mM) which is much lower than that of previous 370 
work (5-20mM) and uniquely examines treatment effects over dynamic muscle contraction, rather 371 
than constant muscle length studies, which may also contribute to the differences in results. 372 
Steele et al. (1990) reported that taurine concentrations greater than 1mM contributed to larger 373 
caffeine induced (10mM) contracture of skinned rat heart tissue. This effect of taurine-caffeine 374 
combined was not transferable to skeletal muscle in the present study when used at a physiological 375 
level (70µM human maximal) of caffeine concentration and the combined effect was not greater 376 
than that of caffeine alone in the present study. Besides the differences in caffeine concentration, 377 
10mM caffeine would be highly toxic for human consumption (Fredholm et al. 1999), it is considered 378 
that the effects of taurine are more profound in heart tissue which may further contribute to the 379 
differences in results (Schaffer et al. 2010).  380 
The caffeine induced increase in muscle power has been attributed to a greater release of Ca2+ into 381 
the intracellular space, an increase in myofibrillar Ca2+ sensitivity, a decrease in the sensitivity of the 382 
SR Ca2+ pump, and an increased SR Ca2+ permeability (Allen et al. 1989, 1995; Tallis et al. 2012, 383 
2013). The present results indicate that a physiological dose of taurine is unable to further modify 384 
the soleus muscle Ca2+ response to electrical stimulation. 385 
 386 
The Effect of Physiological Concentrations of Taurine and Caffeine on Time to Fatigue 387 
Treatment with 2.64mM of taurine failed to significantly affect the time to fatigue in maximally 388 
stimulated mouse soleus muscle compared to controls. When taurine was combined with caffeine 389 
time to fatigue was significantly decreased, although treatment of soleus muscle with caffeine alone 390 
resulted in significantly faster time to fatigue than all other treatments. These results suggest that in 391 
this instance, adding taurine to caffeine may in part block the effects of caffeine alone as the profile 392 
of fatigue is shifted to the right with respect to the caffeine only treatment data (Fig 2). 393 
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A reduction in skeletal muscle taurine content following prolonged muscle stimulation has 394 
previously been established in vitro (Kim et al. 1986; Matsuzaki et al. 2002). Chronic 395 
supplementation has been shown to significantly increase muscle taurine concentration resulting in 396 
increased muscle force production and partially counteracting the effect of intramuscular taurine 397 
depletion that occurs during fatigue (Goodman et al. 2009). Yatable et al. (2003) used a whole 398 
animal model to assess the effects of 7 days of 0.5g/kg taurine supplementation on rat skeletal 399 
muscle taurine content. Skeletal muscles of the leg displayed a significant increase in taurine 400 
concentration post treatment which was followed by an increased time to fatigue of subsequent 401 
treadmill running until exhaustion. Post exercise the supplemented rats demonstrated less of an 402 
exercise related reduction in skeletal muscle taurine concentration compared to controls. The effect 403 
demonstrated from prolonged dietary supplementation of taurine did not prevail in the present 404 
acute study suggesting that any increase in soleus muscle taurine concentration from the given 405 
treatment was not sufficient enough to offset fatigue. 406 
Tallis et al. (2013) discussed that the decreased time to fatigue in caffeine treated soleus muscle was 407 
due to an increase in eccentric work during the lengthening phase of the work loop. In fatigue under 408 
control conditions muscle relaxation time is prolonged due to an increase in intracellular Ca2+ 409 
concentration (Askew, 1997). It is believed that this effect is amplified in the presence of caffeine 410 
resulting in the muscle being active to a greater extent at the end of shortening, hence greater work 411 
is required to stretch the muscle back to its resting length (Tallis et al. 2013). This provides a partial 412 
explanation as to why TC fatigues faster than controls. Silva et al. (2011) demonstrated that chronic 413 
supplementation of taurine in rats (1-ml 300 mg kg−1 per body weight) had a cytoprotective role in 414 
exercise induced muscle injury. Although this mechanism is not ruled out by the authors it is unlikely 415 
that the taurine concentration used in the present study will increase intramuscular taurine levels 416 
enough to generate this mechanism. Moreover, Tallis et al. (2012) highlighted the diverse individual 417 
acute response to 70µM caffeine and a clear division between responders and non-responders to 418 
19 
 
the treatment. The difference in time to fatigue between CAF and TC are most likely to be due to 419 
individual differences in response to the caffeine treatment and the ratio of responders and non-420 
responders between the treatment groups.  This is partly supported in the present study by the 421 
increase in standard error for the TC trial compared to CAF (Fig 2). 422 
 423 
The Effect of Physiological Concentrations of Taurine and Caffeine on Recovery from Fatigue 424 
Treatment of mouse soleus muscle with taurine (T), caffeine (CAF), or taurine and caffeine (TC) 425 
combined failed to affect recovery compared to controls. Similarly, James et al. (2004) reported that 426 
70µM caffeine treatment failed to affect the recovery of both mouse soleus and EDL following 427 
fatigue. The established ergogenic benefit of caffeine on direct muscle power output of non-fatigued 428 
muscle is not great enough to offset the fatigue induced reduction in calcium handling properties 429 
(Allen et al. 2008; Tallis et al. 2012). 430 
Previous work has shown that intramuscular taurine concentration will decrease during fatigue (Kim 431 
et al. 1986; Matsuzaki et al. 2002). Consequently it is considered that the taurine concentration used 432 
in the present work was not significant enough to increase total intramuscular taurine concentration 433 
to a level to induce enhanced muscle recovery. With no significant effect of either taurine or caffeine 434 
alone, it is unsurprising that combining these treatments also failed to elicit an enhanced fatigue 435 
recovery.   436 
 437 
Practical Implications of the Present Findings 438 
The present findings infer that taurine does not provide any acute ergogenic effect directly on 439 
skeletal muscle. However, further research investigating the effect of taurine on other physiological 440 
systems, particularly central effects, should also be considered. Furthermore, in rat skeletal muscle, 441 
20 
 
taurine concentration has been shown to be greater in relatively slow twitch solues muscle (33 μmol 442 
g wet weight−1) compared to relatively fast twitch EDL (17 μmol g wet weight−1; Iwata et al. 1986). 443 
Therefore an interesting area of future research may be to examine whether there is an acute effect 444 
of taurine on relatively fast twitch muscle where a given dose may represent a greater stimulus 445 
relative to normal muscle concentrations of taurine. 446 
 Although evidence for the prolonged supplementation of taurine has been established, achieving 447 
this through the regular consumption of caffeine containing products is not recommended. Regular 448 
consumption of caffeine has been shown to result in habituation and a dampening of the ergogenic 449 
effects, therefore increasing muscular taurine via this method may sacrifice the benefit of caffeine 450 
(Bell & Mcleellan, 2002). In addition to the high quantity of sugar in such drinks, the present findings 451 
and the previous work by Tallis et al. (2012; 2013) have demonstrated that caffeine is likely the key 452 
ingredient in energy drinks to provide an acute effect directly on skeletal muscle performance. 453 
Acute treatment of taurine on isolated skeletal muscle failed to elicit any significant effect on mouse 454 
soleus muscle performance. One off maximal muscle power output, time to fatigue and recovery 455 
from fatigue were all unchanged. Taurine treatment also failed to further potentiate the effects of 456 
caffeine on the same parameters. In conclusion, a physiological level of taurine, to match the blood 457 
plasma that could occur  from acute supplementation of taurine containing products such as energy 458 
drinks, did not provide any direct short term ergogenic benefit in isolated skeletal muscle. 459 
 460 
 461 
 462 
 463 
 464 
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Figures 592 
Figure 1. – The mean acute effect of physiological concentrations of taurine alone (TAU), caffeine 593 
alone (CAF), and taurine and caffeine combined (TC) on work loop power output in maximally 594 
stimulated mouse soleus muscle [Data represented as mean & SE; Original data for CAF published in 595 
Tallis et al. 2012; * represent significant (paired t-test P<0.03) differences in muscle power output, 596 
during the treatment phase, when compared to controls] n=10 for TAU and TC, n=8 for CAF. 597 
Figure 2. – The effects of physiological concentrations of taurine alone (TAU), caffeine alone (CAF), 598 
and taurine and caffeine combined (TC) on time to fatigue in maximally stimulated mouse soleus 599 
muscle. Values are displayed as a percentage of maximal work loop power output. [Data 600 
represented as mean & SE; Original data from CAF published in Tallis et al. 2013; There was a 601 
significant effect of treatment on time to net negative work (ANOVA P<0.001), * # ^ represent 602 
significant (Tukey P<0.001) differences in time to fatigue between treatment groups, whereby any 603 
groups with the same symbol are significantly different from each other] n=8 in each case. 604 
Figure 3 - Effect of physiological concentrations of taurine alone (TAU), caffeine alone (CAF), and 605 
taurine and caffeine combined (TC) on the recovery of mouse soleus muscle following fatigue at 606 
maximal stimulation frequency. Time 60 represents both 60 minutes after the initial treatment 607 
began and the time at which the fatigue run was performed. [Data represented as mean & SE] n = 8 608 
in each case. 609 
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